A comment on: "Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial".
作者信息
Moris Wenke, Koek Ger H, van Deursen Cees Th B M
机构信息
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
School of Nutrition and Translational Research in Metabolism (NUTRIM) University, Maastricht, The Netherlands.
出版信息
Am J Hematol. 2022 Dec;97(12):E482-E483. doi: 10.1002/ajh.26740. Epub 2022 Oct 7.
PMID:36149779
Abstract
摘要
相似文献
1
A comment on: "Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial".
Am J Hematol. 2022 Dec;97(12):E482-E483. doi: 10.1002/ajh.26740. Epub 2022 Oct 7.
2
Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial.质子泵抑制剂治疗遗传性贫血继发血色素沉着症：一项 III 期安慰剂对照随机交叉临床试验。
Am J Hematol. 2022 Jul;97(7):924-932. doi: 10.1002/ajh.26581. Epub 2022 May 10.
3
Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial.质子泵抑制剂可减少 HFE 血色病患者的采血需求：双盲随机安慰剂对照试验。
Gastroenterology. 2017 Sep;153(3):678-680.e2. doi: 10.1053/j.gastro.2017.06.006. Epub 2017 Jun 15.
4
[Hemochromatotic cirrhosis complicating pyridoxine-sensitive hereditary sideroblastic anemia. Case report].
Ann Med Interne (Paris). 1983;134(4):327-32.
5
[An older female patient with refractory anemia and hemochromatosis].[一名患有难治性贫血和血色素沉着症的老年女性患者]
Dtsch Med Wochenschr. 2002 Aug 23;127(34-35):1754-8. doi: 10.1055/s-2002-33548.
6
Should we use proton pump inhibitors as an add-on treatment in hereditary hemochromatosis?我们是否应将质子泵抑制剂用作遗传性血色素沉着症的附加治疗？
Turk J Gastroenterol. 2018 Mar;29(2):254-255. doi: 10.5152/tjg.2018.17713.
7
Hereditary hemochromatosis in a patient with congenital dyserythropoietic anemia.一名先天性红细胞生成异常性贫血患者的遗传性血色素沉着症。
Blood. 2000 Nov 15;96(10):3653-5.
8
Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis.质子泵抑制剂可降低 HFE 相关性血色病患者的采血负担：系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2021 Oct 1;33(10):1327-1331. doi: 10.1097/MEG.0000000000001857.
9
An hereditary anemia with hemochromatosis; studies of an unusual hemopathic syndrome resembling thalassemia.
Am J Med. 1958 Aug;25(2):303-14. doi: 10.1016/0002-9343(58)90036-6.
10
When and how should we screen for hereditary hemochromatosis?我们应该在何时以及如何筛查遗传性血色素沉着症？
Joint Bone Spine. 2003 Aug;70(4):263-70. doi: 10.1016/s1297-319x(03)00035-6.
Zotero 插件